Novartis and Amgen announce FDA approval of Aimovig
Basel, SWITZERLAND – Novartis announced that the U.S. Food and Drug Administration (FDA) has approved Aimovig (erenumab) for the preventive treatment of migraine in adults.
Pharmacy
Medicare rolls out diabetes prevention program
Millions of U.S. seniors can now take part in a Medicare program designed to prevent prediabetes from progressing to type 2 diabetes. Almost half of Americans 65 and older have prediabetes, and many don’t know it.
FDA approves US WorldMeds’ Lucemyra for opioid withdrawal symptoms
US WorldMeds announced that the U.S. Food and Drug Administration (FDA) approved Lucemyra (lofexidine) for mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults.
FDA approves new preventive treatment for migraines
The U.S. Food and Drug Administration (FDA) has approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections.
Online grocery sales boost Walmart’s Q1 growth
Walmart on Friday reported fiscal first quarter income of $2.1 billion on a 4.4% increase in revenue, to $122.7 billion, thanks largely to a jump in online grocery sales. Walmart’s digital sales increased 33% in the quarter ended April 27.
McKesson HVS partners with Discount Drug Mart
McKesson High Volume Solutions (HVS) announced a pharmacy automation agreement with Discount Drug Mart, Inc., an Ohio-based retail drug store chain that operates more than 70 pharmacies in the state.
Albertsons, Rite Aid unveil merger’s strategies and synergies
Albertsons Cos. and Rite Aid Corp. on Tuesday hosted a joint analyst event to discuss the strategic and financial benefits of the proposed merger transaction between the two companies.
Novartis announces FDA approval of Gilenya
Novartis announced that the U.S. Food and Drug Administration (FDA) has approved Gilenya (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with relapsing forms of multiple sclerosis, making it the first disease-modifying therapy indicated for these patients.
NACDS issues memo to chain members on administration’s drug pricing policies
NACDS today sent the following memo to chain members: We are writing to update you on President Trump’s announcement today regarding prescription drug pricing policies, and anticipated future events related to it.
Retailers praise Trump for taking on drug prices
CVS Health and Walgreens have commended President Trump for vowing in a speech today to fight high drug prices.
Metro completes Coutu acquisition
Metro Inc. has completed its $4.5 billion ($3.6 billion U.S.) acquisition of the Jean Coutu Group, creating a food and drug retailer with more than 1,300 stores in Quebec, Ontario and New Brunswick.
PANTHERx selected by Otsuka to distribute Jynarque
PANTHERx Specialty Pharmacy has been selected by Otsuka America Pharmaceutical, Inc. to distribute Jynarque (tolvaptan), the only FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease (ADPKD).
Express Scripts shows SafeGuardRx program offering better care at lower cost
Express Scripts released new data today showing significantly improved clinical outcomes and lower drug spending for patients with complex, high-cost conditions who are enrolled in a suite of technology-supported, value-based SafeGuardRx programs.